Coronavirus News Roundup: Kroger to Provide COVID-19 Antibody Tests, Global Survey Assesses COVID-19 Vaccine Acceptance

October 30, 2020
Drug Topics staff

Here's the coronavirus-related news from this week that you should know. 

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), has infected an estimated 39,068,667 individuals worldwide at publishing time, and nearly 8 million Americans. In the latest COVID-19 related news, Kroger Health is offering rapid antibody testing and a recent survey showed wide variation of acceptance rates for a vaccine.

Here’s a roundup of the latest coronavirus-related news:

Kroger Pharmacies to Provide COVID-19 Antibody Tests

Kroger Health is offering rapid antibody testing for COVID-19 across all its pharmacies and clinics by the end of November.

Read more

ThoughtSpot 2020 Series: Episode 10: Supporting Marginalized Communities During Natural Disasters

For our first episode in the ThoughtSpot 2020 series, experts from AmerisourceBergen and Healthcare Ready discuss how to support marginalized communities amid pandemics and natural disasters.

Listen to the podcast

Eli Lilly Ends Trial for Bamlanivimab in Hospitalized COVID-19 Patients

Investigators from Eli Lilly’s ACTIV-3 clinical trial investigating bamlanivimab in patients hospitalized with COVID-19 have discontinued the trial after concluding that the therapy showed no benefit. No additional COVID-19 patients in the hospitalized setting will receive bamlanivimab, according to a statement by Eli Lilly.

Read more

Survey: Varied Responses on Acceptance of a COVID-19 Vaccine Worldwide

Results of a survey from the City University of New York Graduate School of Public Health and Health Policy showed that acceptance rates of a COVID-19 vaccine varied widely among populations; individuals who reported higher levels of trust in information from their government were more likely to accept a COVID-19 vaccine.

Read more

Related Content:

Coronavirus